#Pre-Filled Auto Injectors Market share
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
There are dozens of funny blogs to kill time on Tumblr.
Text
#Pre-Filled Auto Injectors Market#Pre-Filled Auto Injectors Market share#Pre-Filled Auto Injectors Market size
0 notes
Photo
Pre-Filled Auto Injectors Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast
#Pre-Filled Auto Injectors Market Share#Pre-Filled Auto Injectors Market Size#Pre-Filled Auto Injectors Market Trend#Pre-Filled Auto Injectors Market
0 notes
Link
Pre-filled auto-injectors are defined as unit dose medication for parenteral administration. Pre-filled auto-injectors are intended for self-administration by patients.
#Pre-Filled Auto Injectors Market Share#Pre-Filled Auto Injectors Market Analysis#Pre-Filled Auto Injectors Market Trends#Pre-Filled Auto Injectors Market Growth
0 notes
Text
Injectable Drug Delivery Technology Market Dynamics, Emerging Trends and Growth Factors Forecast 2022-2030
Acumen Research and Consulting announced the latest market research report on "Global Injectable Drug Delivery Technology Market : Global Industry Size, Share, Trends and Forecast, 2018 - 2026”.
The global Injectable Drug Delivery Technology Market research report is inclusive of detailed and productive qualitative and quantitative information, for the historic period, base year, and the forecast period, which can benefit the user for taking the appropriate decision on the basis of market knowledge, as well as for gathering valuable information for further estimations. Download FREE SAMPLE PDF (Including Full TOC, Table & Figures) @ https://www.acumenresearchandconsulting.com/request-sample/859
The detailed information of the global Injectable Drug Delivery Technology Market about the driving factors, development strategies such as new product development, mergers and acquisition, and partnerships & collaboration, recent trends, as well as challenges and opportunities are incorporated for a more extensive understanding of the market potential.
Moreover, the global market is finely segmented and on the basis of geography segmented across North America (US and Canada), Europe (UK, Germany, France, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East and Africa (GCC, South Africa, and Rest of Middle East & Africa). And the regions are further studied across the respective major countries including detailed current trends and available opportunities in the respective market. Segmentation
Market By Formulation
Nanoparticles Liposomes Microspheres Others
Market By Device Type
Needle Free Injectors Reusable Needles Pre-Filled Syringes Auto Injectors Pen Needle Disposable Syringes Others
Market By Mode Of Delivery
Intraperitoneal Intravenous Intramuscular Subcutaneous Others
Market By Application
Oncology Orphan Diseases Auto-Immune Disease Others
Global Injectable Drug Delivery Technology Market : Competitive Landscape
Along with this, the research report encompasses comprehensive information of market leaders that majorly include a business overview, financial overview, product offerings, strategic developments, and geographical presence. The profiled players are collaboratively analyzed for digging out the market scenarios in a more competitive manner.
Essentially, it’s a well-compiled solution for the industry players, managers, researchers, strategists, consultants, education organizations, students, and start-ups. They can get the required information in an easy and understandable format for the required task and will be able to interpret in almost no time and able to saves time. Moreover, in case of further customization or addition required in the report scope, our team is able to provide for meeting the expectations of users. Who are the key players in the market? The key players operating in Injectable Drug Delivery Technology Market such as Key Players:
The injectable drug delivery technology market comprises of some of the major players such as Alkermes Inc., Bend Research, Polymer Factory, Genentech Inc., MicroCHIPS, Inc., Presage Bioscience, QLT Inc., BIND Biosciences, Inc., Endocyte, Pearl Therapeutics Inc., and UCB Group. Overview of the Impact of COVID-19 on Injectable Drug Delivery Technology Market : The development of COVID-19 has carried the world to a stop. We comprehend that this health emergency has brought an unprecedented effect on businesses across ventures. However, this also will pass. Rising help from governments and a few organizations can help in the battle against this profoundly infectious sickness. There are a few industries that are battling and some are flourishing. In general, pretty much every segment is foreseen to be affected by the pandemic. We are making persistent efforts to enable your business to continue and develop during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across ventures to assist you to prepare for the future. In a nutshell, the global Injectable Drug Delivery Technology Market research report encompasses the desired information in terms of both quality and quantity with the respective market. The collection of information is completely based on the authorized sources and compiled by the experts and research analysts with years of experience in the respective industry vertical.
Inquiry Before Buy Report @ https://www.acumenresearchandconsulting.com/inquiry-before-buying/859 Few Significant Points From Table Of Content:
CHAPTER 1.INDUSTRY OVERVIEW
Definition of Injectable Drug Delivery Technology
Market Segmentation
List of Abbreviations
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison By Formulations (2015-2026)
Global Injectable Drug Delivery Technology Market Revenue Share By Formulations in 2017
Nanoparticles
Liposomes
Microspheres
Others
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison By Device Type (2015-2026)
Needle Free Injectors
Reusable Needles
Pre-Filled Syringes
Auto Injectors
Pen Needle
Disposable Syringes
Others
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison By Mode Of Delivery (2015-2026)
Intraperitoneal
Intravenous
Intramuscular
Subcutaneous
Others
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison By Application (2015-2026)
Oncology
Orphan Diseases
Auto-Immune Disease
Others
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
North America Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
Europe Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
Asia-Pacific Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
Latin America Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
Middle East and Africa (MEA) Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
CHAPTER 2.MARKET DYNAMICS AND COMPETITION ANALYSIS
Market Drivers
Restraints and Challenges
Growth Opportunities
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of Substitute
Threat of New Entrants
Degree of Competition
Value Chain Analysis
Raw Material and Suppliers
Manufacturing Process Analysis
Regulatory Compliance
Player Positioning Analysis
Key Strategies Adopted By Leading Players
CHAPTER 3.MANUFACTURING PLANTS ANALYSIS
Capacity and Commercial Production Date of Global Injectable Drug Delivery Technology Major Manufacturers in 2017
Manufacturing Plants Distribution of Global Injectable Drug Delivery Technology Major Manufacturers in 2017
R&D Status and Technology Source of Global Injectable Drug Delivery Technology Major Manufacturers in 2017
Raw Materials Sources Analysis of Global Injectable Drug Delivery Technology Major Manufacturers in 2017
CHAPTER 4.INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY FORMULATION
Global Injectable Drug Delivery Technology Revenue By Formulation
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5.INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY DEVICE TYPE
Global Injectable Drug Delivery Technology Revenue By Formulation
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6.INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY MODE OF DELIVERY
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7.INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY APPLICATION
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 8.NORTH AMERICA INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
North America Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
North America Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
U.S. Injectable Drug Delivery Technology Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 9.EUROPE INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Europe Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Europe Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 10.ASIA-PACIFIC INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Asia-Pacific Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Asia-Pacific Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 11.LATIN AMERICA INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Latin America Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Latin America Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 12.MIDDLE EAST INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Middle East Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Middle East Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 13.AFRICA INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Africa Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Africa Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 14.COMPANY PROFILE
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
CHAPTER 15.RESEARCH APPROACH
Initial Data Search
Secondary Research
Primary Research
Assumptions and Scope
Customized Requirements? Inquiry Before Buying? Please Email us at [email protected] | Single User License US$ 4500
The Final Report will cover the impact analysis of COVID-19, Download Full Study Report (Single User License US$ 4500)@ https://www.acumenresearchandconsulting.com/buy-now/0/859 Key Questions Answered in the Report The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include- - What is the overall structure of the market? - What was the historical value and what is the forecasted value of the market? - What are the key product level trends in the market? - What are the market level trends in the market? - Which of the market players are leading and what are their key differential strategies to retain their stronghold? - Which are the most lucrative regions in the market space? The report is readily available and can be dispatched immediately after payment confirmation.
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 20 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country-level expertise.
For more information, please contact:
Frank Wilson
Acumen Research And Consulting Email: [email protected] Tel: +14079154157
Related Links https://www.acumenresearchandconsulting.com/
0 notes
Text
Injectable Drug Delivery Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2030
The report studies the historical data of the Injectable Drug Delivery Market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report offers an accurate forecast estimation of the Injectable Drug Delivery Market based on the recent technological and research advancements.
The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to latest analysis by Emergen Research. Injectable drug delivery market revenue growth is owing to a rising trend of pre-filled syringes along with technological developments. Initially, medication was only available in the form of tablets, pills, or capsules; however, medicines are now given via more technologically advanced and intelligent methods. These systems are meant to deliver medications to a specific location, allowing them to be more localized than would be possible through the circulatory system.
Advanced injectable devices are preferred by patients who take medications daily over standard injection devices. As a result, growing demand for effective and convenient drug delivery systems gives manufacturers a potential growth opportunity to develop advanced, user-friendly, and effective drug delivery devices. Increasing frequency of chronic illnesses and other life-threatening disorders highlights the need for new and effective medications across a wide range of treatment areas.
Get a sample of the report @ https://www.emergenresearch.com/industry-report/injectable-drug-delivery-market
Regional Analysis - The research report is an investigative study providing a conclusive view of the Injectable Drug Delivery business sphere by an in-depth segmentation of the market into key applications, types, and regions. These segments are analysed on the basis of present, emerging, and future trends. The regional segmentation provides current and forecast demand estimation for the Injectable Drug Delivery industry in key regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Some major companies in global market report include Vetter Pharma, Akorn Operating Company LLC, Catalent, Inc., Pfizer Inc., Gerresheimer AG, Elcam Medical, Schott, SHL Medical AG, Becton, Dickinson & Company, and West Pharmaceutical Services, Inc.
Key questions addressed in the report:
What are the key factors driving the global Injectable Drug Delivery market?
Who are the key manufacturers in this market space?
Who are the distributors, traders and dealers of this market?
What are the market opportunities and risks affecting the performance of the vendors in the global Injectable Drug Delivery market?
What are the sales and revenue estimations for the top manufacturers in this market over the projected timeline?
Emergen Research has segmented global injectable drug delivery market on the basis of device type, product type, end-use, and region:
Device Type Outlook (Revenue, USD Billion; 2019-2030)
Product Type Outlook (Revenue, USD Billion; 2019-2030)
End-use Outlook (Revenue, USD Billion; 2019-2030)
Conventional Injectables
Pre-Filled Syringes
Auto-Injectors
Pen-Injectors
Freeze-Dried Products
Injectable Sterile Products
Hospitals
Homecare Settings
Clinics
Others
Key point summary of the report:
The report offers a comprehensive overview of the market size, share, and growth rate in the forecast duration.
It provides details about current scenario, historical data, giving an accurate market forecast for the coming years.
The study categorizes the market on the basis of product types, applications, end users, market value and volume, business verticals, and 5 major regions.
It also offers regional market analysis and forecast for prominent geographies in the sector viz., North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Take a Look at our Related Reports:
Industry 4.0 Market
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/industry-4-market
Big Data Analytics in Manufacturing Market
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/big-data-analytics-in-manufacturing-market
Next-Generation Biomanufacturing Market
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/next-generation-biomanufacturing-market
Deep Learning Chip
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/deep-learning-chip-market
Vehicle-to-Everything (V2X)
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/vehicle-to-everything-market
Big Data Analytics in BFSI
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/big-data-analytics-in-bfsi-market
Structured Cabling Market
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/structured-cabling-market
Deep Learning System
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/deep-learning-system-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
0 notes
Text
Connected Drug Delivery Devices Market: Current Analysis and Forecast (2021-2027)
Connected drug delivery devices are mainly developed for the supervision and counseling of patients in a home setting. These devices offer various advantages such as adherence trackers, dose reminders, and monitoring of various diseases such as asthma, clinically isolated syndrome, Chronic Obstructive Pulmonary Disease (COPD), diabetes, and hypertension. Moreover, the sensors incorporated in the delivery devices help to monitor the side effects and evaluation of the effect of change in dose. The adherence trackers help to check whether the patients are taking the required dose at right time or not, whereas the apps associated with the connected delivery devices help to record the effect of treatment, safety of dose, and tolerability. Flexi-Q eMU-P electromechanical multi-use auto-injector system consists of a single-use cassette, reusable device, and a pre-filled syringe. This device is mainly used for various diseases which require a repeated dose of injections, such as autoimmune diseases, multiple sclerosis, blood-related disorders, and growth hormone deficiencies. The main advantage of Flexi-Q eMU-P is that it is reusable and easily affordable. The demand for Connected drug delivery devices is increasing on account of increasing penetration of the Internet of Things (IoT) in the healthcare devices, increasing focus on patient compliance, quality of healthcare, rising awareness of costs, increasing use of self-administered drugs, rising healthcare programs, and initiatives to spread the connected drug delivery devices' awareness. For example, Propeller Health company has conducted around 60 connected medical programs to spread awareness of connected drug delivery devices. The company provides add-on devices for inhalers that are synchronized with the patient's software for the analysis of symptoms and diseases.
Insights Presented in the Report
"Amongst Products, Connected sensors segment holds the major share."
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/connected-drug-delivery-devices-marketcurrent-forecast-market-2021-2027-860
Based on Products, the global Connected drug delivery devices market is fragmented into Connected Sensors and Integrated Connected Devices. The connected sensors segment is expected to dominate the market owing to its easy integration inside the already existing delivery devices without any interruption in their normal functioning.
"Amongst Connected Sensors, Connected Inhaler Sensors is anticipated to grow at the highest CAGR during the analyzed period."
Connected Sensors are further bifurcated into Connected Inhaler Sensors and Connectable Injection Sensors. The demand for connected inhaler sensors is on rise on account of the high prevalence of respiratory diseases. Several research companies are working to control the incidence of respiratory diseases, for instance, propeller health is providing digital health solutions for respiratory medicine with the combination of analytics, inhaler device sensors, and mobile applications. Propeller Health has launched several connected inhaler device sensors such as metered-dose inhalers (MDIs), dry powder inhaler (DPI), and soft mist inhaler (SMI) for the monitoring of COPD and Asthma.
Amongst Integrated Connected Devices, the Connected Inhaler Devices segment holds the major share"
The integrated connected devices are expected to register the fastest CAGR in the upcoming period. The integrated connected devices segment is also sub-divided into Connected Inhaler Devices and Connected Injection Devices. Connected Inhaler Devices hold several benefits over the Connected Injection Devices because of the needleless delivery of the drug. The demand for inhalational devices in the market is increasing owing to the high prevalence of chronic diseases such as Chronic Obstructive Pulmonary Disease (COPD), and asthma. As per Burden of Obstructive Lung Disease (BOLD), the global prevalence of COPD is 10.1% in 2019.
Amongst Technology, the Bluetooth segment holds the major share"
Based on Technology, the market is fragmented into Bluetooth, Near-field communication (NFC), and Other Technologies. Bluetooth sub-segment is expected to show significant growth in the forecast period owing to its high use in drug delivery devices, and its low-cost connectivity access to smartphones. The Bluetooth technology is easily available in comparison to NFC and other technologies. For example, Teva a pioneer in enhancing health and improving access to quality healthcare for society has launched a Bluetooth-enabled albuterol sulfate rescue inhaler. The new inhaler is available by prescription to U.S. patients age 4 and older, according to the Tel Aviv, Israel-based company. ?ProAir Digihaler' connects with the smartphone to detect and record COPD and Asthma symptoms.
Amongst End-User, the Homecare segment holds the major share"
Based on End-user, the market is divided into Healthcare Providers, Homecare, Hospitals, and Others. The home care segment is expected to register the fastest CAGR from 2021-2027 because of the rise in product acceptance. The advantage of using these products in the homecare setting is easy administration and without the need for healthcare practitioners. Furthermore, the increasing incidents of chronic diseases such as diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Cardiovascular Diseases (CVDs) are expected to fuel the homecare segment growth in the forecast period. For instance, as per WHO, Cardiovascular diseases (CVDs) are the number 1 cause of death globally, taking an estimated 17.9 million lives each year. Four out of 5CVD deaths are due to heart attacks and strokes, and one-third of these deaths occur prematurely in people under 70 years of age.
"North America is the largest markets and Europe is expected to be the fastest-growing markets"
For a better understanding of the market adoption of the Connected Drug Delivery Devices, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World.
Competitive Scenario
Some of the major players operating in the market include Propeller Health (Reciprocal Labs Corporation), Proteus Digital Health, BIOCORP, Merck KGaA, Adherium Limited, West Pharmaceutical Services, Inc., Aterica Digital Health, Phillips Medisize, Teva Pharmaceutical Industries Ltd and FindAir . Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions
Reasons to buy this report:
? The study includes market sizing and forecasting analysis validated by authenticated key industry experts
? The report presents a quick review of overall industry performance at one glance
? The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
? Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
? The study comprehensively covers the market across different segments
? Deep dive regional level analysis of the industry
Customization Options:
Connected Drug Delivery Devices Market can further be customized as per the requirement or any other market segment.
Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/connected-drug-delivery-devices-marketcurrent-forecast-market-2021-2027-860
Table of content
1 MARKET INTRODUCTION 1.1 Market Definitions 1.2 Limitation 1.3 Stake Holders 1.4 Currency Used in Report 2 RESEARCH METHODOLOGY OR ASSUMPTION 2.1 Research Process of the Connected Drug Delivery Devices Market 2.2 Research Methodology of the Connected Drug Delivery Devices Market 2.3 Forecasting Method 2.4 Respondent profile 2.5 Main Objective of the Connected Drug Delivery Devices Market Study 3 MARKET SYNOPSIS 4 EXECUTIVE SUMMARY 5 GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET ANALYSIS 2019-27F 6 MARKET INSIGHTS BY PRODUCTS 6.1 Integrated Connected Devices 6.1.1 Connected Inhaler Devices 6.1.2 Connectable Injection Devices 6.2 Connected Sensors 6.2.1 Connected Inhaler Sensors 6.2.2 Connected Injection Sensors 7 MARKET INSIGHTS BY TECHNOLOGY 7.1 Bluetooth 7.2 Near-field communication (NFC) 7.3 Other Technologies 8 MARKET INSIGHTS BY END-USER 8.1 Healthcare Providers 8.2 Homecare 8.3 Hospitals 8.4 Other end-users 9 MARKET INSIGHTS BY REGION 9.1 NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET 9.1.1 United States 9.1.2 Canada 9.1.3 Rest of North America 9.2 EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET 9.2.1 Germany 9.2.2 France 9.2.3 United Kingdom 9.2.4 Italy 9.2.5 Spain 9.2.6 Rest of Europe 9.3 ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET 9.3.1 China 9.3.2 Japan 9.3.3 India 9.3.4 Australia 9.3.5 Rest of Asia Pacific 9.4 REST OF WORLD CONNECTED DRUG DELIVE
CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170 / +91 8087042414 Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
0 notes
Text
Novartis set to overcome $14 billion patent cliff say analysts
Novartis’ pipeline is strong enough to overcome a $14 billion patent cliff as blockbuster drugs face generic competition in the coming years, analysts have said.
Following a briefing with management, a team of analysts led by Peter Welford said that the big Swiss pharma will be propped up by its psoriasis and infectious diseases blockbuster Cosentyx for some time.
Although the drug has lost market share to rivals in psoriasis, there is still more to come from Cosentyx thanks to potential new uses in ankylosing spondylitis, psoriatic arthritis and six new indications.
This will be helped by a new 300mg pre-filled syringe and auto-injector have halved administrations, although there is an intravenous option for administration by doctors treating US Medicare patients.
This is supported by the company’s portfolio of other approved medicines and revenues from its Sandoz biosimilars and generics division.
In the short term, the analysts predict “flattish” Q4 sales, although they noted that the company may benefit from cost savings introduced during the COVID-19 pandemic.
Jefferies expects that the company expects sales of $14 billion could be at risk by 2027 from patent expiries of Tasigna, Promacta, Jakavi, Gilenya and Entresto.
But the analysts said that sales growth will continue despite the headwind thanks to “underappreciated” drugs in the late-stage pipeline.
Four key drugs outlined by Jefferies have combined peak potential of $14 billion ��� the high lipoprotein cardiovascular disease drug pelacarsen, iscalimab for organ transplant and Sjogren’s syndrome, the rare disease drug iptacopan and the leukaemia drug sabatolimab.
Other important phase 3 drugs that are due to read out are Lu-PSMA in prostate cancer and canakinumab in lung cancer.
The company’s Sandoz division will also chip in with growing sales from its portfolio of biosimilars – cut-price near-copies of established biologic drugs that have been shown to be as safe and effective in rigorous tests and clinical trials.
Uptake of biosimilars in the US has been better than hoped, perhaps aided by hospitals focusing on cost because COVID-19 has curtailed income from surgery.
The post Novartis set to overcome $14 billion patent cliff say analysts appeared first on .
from https://pharmaphorum.com/news/novartis-set-to-overcome-14-billion-patent-cliff-analyst/
0 notes
Text
By 2026, Injectable Drug Delivery Market To Surpass US$ 32.5 - Coherent Market Insights
From 2018 – 2026, The global injectable drug delivery market is expected to exhibit a CAGR of 8.3%
Request for Sample PDF Copy:
https://www.coherentmarketinsights.com/insight/request-pdf/2768
Description:
Injectable drug delivery is considered as the most effective route of administration for the effective delivery of drugs to the targeted site, which enhances the patient’s compliance to the drug. The Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action.
The global injectable drug delivery market size was valued at US$ 15,939.0 million in 2017, and is expected to exhibit a CAGR of 8.3% over the forecast period (2018 – 2026).
Figure 1. Global Injectable Drug Delivery Market Value (US$ Mn), by Region, 2017
Injectable Drug Delivery | Coherent Market Insights
Increasing prevalence of chronic diseases such as diabetes and anaphylaxis is expected to propel growth of the global injectable drug delivery market
Increasing prevalence of chronic diseases such as diabetes and other diseases is expected to drive the market growth. According to the World Health Organization (WHO), in November 2011, around 60 million people in Europe suffered from diabetes, of which around 10.3% were men and 9.6% were women aged 25 years and above. Similarly, according to World Health Organization (WHO) 2018 factsheet, around 8.5% adults aged 18 years and above had diabetes in 2014 globally.
Moreover, the market players are focused on product development and launch of injectors, which is expected to propel growth of the global injectable drug delivery market over the forecast period. For instance, in 2016, Berlin-Chemie launched BerliPen areo 3 in Germany. BerliPen areo 3 is a 300 unit insulin pen, which can be used with six different insulins in the treatment of type 1 and 2 diabetes. Similarly, in August 2018, Teva Pharmaceuticals received the U.S. Food and Drug Administration (FDA) approval for generic version of Mylan’s EpiPen and EpiPen Jr. Teva Pharmaceuticals is the first generic manufacturer that received the FDA approval.
However, increasing product recalls is expected to hinder the market growth. In December 2012, Bracco Diagnostics Inc., initiated a Class I recall of nine lots of Isovue Pre-Filled Power Injector Syringes, which are to be used with Stellant CT Injection Systems, due to presence of visible particles in syringes observed at the end of standard stability studies on retained samples, according to the U.S. Food and Drug Administration (FDA)
Figure 2. Global Injectable Drug Delivery Market Share (%), by Usability,2018 and 20 Injectable Drug Delivery | Coherent Market Insights
Source: Coherent Market Insights Analysis (2019)
Increasing product approval and launch in North America is expected to bolster the market growth
North America holds dominant position in the global injectable drug delivery market, owing to increased focus of regional players in research and development and product launches. In 2017, Bayer received U.S. Food and Drug Administration (FDA) approval for a connected auto-injector-BETACONNECT for relapsing-remitting multiple sclerosis medication and companion app- myBETAapp. The app allows patients to automatically have a record of all their injections and share that record with their nurse or physician. Similarly, in October 2018, Genentech announced the U.S. Food and Drug Administration (FDA) approval for single-dose prefilled syringes (PFS) for Xolair (omalizumab) as an additional formulation for both allergic asthma and chronic idiopathic urticaria (CIU) indications.
Moreover, increasing incidence of chronic diseases such as anaphylaxis, diabetes, and cardiac arrest in the region is expected to support growth of the market during the forecast period. For instance, according to Journal of Allergy and Clinical Immunology, 2014, prevalence of anaphylaxis in the U.S. was 1.6% in the general population, while the number of hospitalizations associated with the disease is ever increasing in the U.S.
Furthermore, increasing initiatives by companies to make auto-injectors available to patients suffering from anaphylaxis is expected to boost global injectable drug delivery market. For instance, Mylan N.V. provides discount cards to epinephrine buyers, and offers discounts up to US$ 300 on branded version of EpiPen and up to US$ 25 on the approved generic version of EpiPen.
Key Players
Major players operating in the global injectable drug delivery market include Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, and Injex Pharma GmbH
About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We do offer wide range of services such as Industry analysis, Consulting services, Market Intelligence, Customized research services and much more. We have expertise in many fields such as healthcare, chemicals and materials, Automation, semiconductors, electronics, energy, food and beverage, packaging and many more. Visit our website to know more.
Buy Report Here:
https://www.coherentmarketinsights.com/insight/buy-now/2768
Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave. #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
0 notes
Text
Auto Injectors Market to Witness a Pronounce Growth during 2018-2027
Auto-injector devices are defined as the new injectable, with a user-centric design approach that automatically injects a needle and performs the surgical procedures in order to increase self-injectable devices and reduce dependence on healthcare professionals. These are specialized instruments that can be used to avoid needle stick injury and reduce needle phobia among patients. These are the revolutionary instruments which are invented to ensure complete dosage with painless drug delivery. Factors such as rising prevalence of anaphylaxis, rheumatoid arthritis and multiple sclerosis is anticipate to increasethe consumption of auto-injectors over the forecast period. Factors like growing advancement in the drug delivery technology, growing patient preferences for Auto-injectorsin emergency care and increasing number of key participantsmanufacturing generic versions are anticipated to enhance the growth of global Auto-injectorsmarket over the forecast period.
Get Sample Copy Of The Report@ https://www.trendsmarketresearch.com/report/sample/3310
Sale of Auto-injectorsis relativelyhealthy in the U.S. market in the recent years, making North America the most lucrative region globally.North America Auto-injectorsmarketis estimated to value at US$ XX.XMn in 2016, with the U.S. accounting for majority of revenue share. By product, PrefilledAuto-injectorsaccounted for higher revenue share in global Auto-injectorsmarketas compared to other product segments..
By Indication type, anaphylaxis indication type segment accounted for highest revenue share and is expected to reflect CAGR the forecast period. The growing preference for injectable drug delivery is expected to fuel the market for sterile drugs globally. Self-administration of drugs through usage of pre-filled syringes is one such instance where patients can save on large caregiver fees. There is an increased demand for large molecule drugs in pre-filled syringes as compared to small molecule drugs in pre-filled syringes.
By Distribution Channel, Online Pharmacies segmentaccount for higher demand for Auto-injectorsas compared to other end user segments such as Drug Stores, Hospital Pharmacies and Retail Pharmacies segment.PrefilledAuto-injectorscherishsupportable demand for Online Pharmacies owing to the fact that Epipen Auto Injector which is used in anaphylaxis is made mandatory at several public places along with the first aid.
Report For Sample with TOC@ https://www.trendsmarketresearch.com/report/requesttoc/3310
Moreover certain change in prices made by Mylan N.V. by launching a generic version of Epipen is expected to drastically affect the sales revenue of auto-injectors market in the near future. The prices are dropped down to nearly half of the initial prices that will affect the sales revenue but will eventually support to build a strong volume base for auto-injectors market.
Key players in the global Auto-injectors market include Becton, Dickinson and Company, Sanofi, Pfizer, Inc., Mylan N.V., Novartis AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc. and Eli Lilly and Company and others. Major market players are implementing different strategies and are focusing on product development through research. Many players have are yet to launch the auto injectors in the market and are soon expected to launch.
Report Analysis@ https://www.trendsmarketresearch.com/report/auto-injectors-market
Contact Us:
One Vincent Square Westminster, London SW1P 2PN United Kingdom Phone: +442033221521 Email: [email protected] Website: https://www.trendsmarketresearch.com
0 notes
Text
Auto Injectors Market Key Development the COVID-19
Auto-injector devices are defined as the new injectable, with a user-centric design approach that automatically injects a needle and performs the surgical procedures in order to increase self-injectable devices and reduce dependence on healthcare professionals. These are specialized instruments that can be used to avoid needle stick injury and reduce needle phobia among patients. These are the revolutionary instruments which are invented to ensure complete dosage with painless drug delivery. Factors such as rising prevalence of anaphylaxis, rheumatoid arthritis and multiple sclerosis is anticipate to increasethe consumption of auto-injectors over the forecast period. Factors like growing advancement in the drug delivery technology, growing patient preferences for Auto-injectorsin emergency care and increasing number of key participantsmanufacturing generic versions are anticipated to enhance the growth of global Auto-injectors market over the forecast period.
Sale of Auto-injectorsis relativelyhealthy in the U.S. market in the recent years, making North America the most lucrative region globally.North America Auto-injectorsmarketis estimated to value at US$ XX.XMn in 2016, with the U.S. accounting for majority of revenue share. By product, PrefilledAuto-injectorsaccounted for higher revenue share in global Auto-injectorsmarketas compared to other product segments..
Request For Report sample @ https://www.trendsmarketresearch.com/report/sample/3310
By Indication type, anaphylaxis indication type segment accounted for highest revenue share and is expected to reflect CAGR the forecast period. The growing preference for injectable drug delivery is expected to fuel the market for sterile drugs globally. Self-administration of drugs through usage of pre-filled syringes is one such instance where patients can save on large caregiver fees. There is an increased demand for large molecule drugs in pre-filled syringes as compared to small molecule drugs in pre-filled syringes.
By Distribution Channel, Online Pharmacies segmentaccount for higher demand for Auto-injectorsas compared to other end user segments such as Drug Stores, Hospital Pharmacies and Retail Pharmacies segment.PrefilledAuto-injectorscherishsupportable demand for Online Pharmacies owing to the fact that Epipen Auto Injector which is used in anaphylaxis is made mandatory at several public places along with the first aid.
Moreover certain change in prices made by Mylan N.V. by launching a generic version of Epipen is expected to drastically affect the sales revenue of auto-injectors market in the near future. The prices are dropped down to nearly half of the initial prices that will affect the sales revenue but will eventually support to build a strong volume base for auto-injectors market.
Key players in the global Auto-injectors market include Becton, Dickinson and Company, Sanofi, Pfizer, Inc., Mylan N.V., Novartis AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc. and Eli Lilly and Company and others. Major market players are implementing different strategies and are focusing on product development through research. Many players have are yet to launch the auto injectors in the market and are soon expected to launch.
More Info of Impact Covid19 @ https://www.trendsmarketresearch.com/report/covid-19-analysis/3310
0 notes
Text
Asia Pacific (APAC) Drug Delivery Devices Market - Trends and Forecast to 2024
Asia Pacific Drug Delivery Devices Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical, Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Ambulatory Surgery Centers/Clinics, Home Care Settings, Diagnostic Centers, Others), By Country (China, India, Japan, South Korea, Singapore, Australia, Rest of APAC) – Industry Trends and Forecast to 2024
APAC Drug Delivery Devices Market is expected to reach USD 235.8 billion by 2024 from USD 130.9 billion in 2016, at a CAGR of 7.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Drug delivery is a process of introducing a therapeutic effect in the human body by administering a pharmaceutical drug at a specific targeted site. Drug delivery system improves the efficacy and safety of drug by controlling the rate, time and release of drug in the body. The drug delivery market is segmented on the basis of route of administration, end users, and region.
Request-a-sample@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-apac-drug-delivery-devices-market
· On the basis of route of administration the APAC drug delivery devices market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug.
· The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups.
· The Injectable drug delivery segment is further segmented into devices and formulations. The devices segment is categorized as conventional injections, self Injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices. The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes.
· The Injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable. Based on the route of administration, oral drug delivery market dominates the market in 2015 and in the near future injectable drug delivery market will dominate the APAC drug delivery devices market with the largest share in the drug delivery market. Topical drug delivery market is considered to be the fastest growing market with the CAGR of 11.5%.
Speak-to-analyst@https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-apac-drug-delivery-devices-market
The pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.
Ocular drug delivery devices are segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays. Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.
Nasal drug delivery devices are segmented into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal. The transdermal topical drug delivery device includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sunlingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
On the basis of end users the APAC drug delivery devices market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others. The hospitals segment dominate the North America drug delivery devices market.
The major factors contributing to the growth of the APAC drug delivery devices market are rising prevalence of chronic diseases, growing geriatric population, increase in diagnosis, growth of biosimilars, new product launches, drug innovation, technological advancements, and decrease in the level of pain. On the other hand, factors such as side effects and injuries, infections, safety measures regarding the use of devices used for the administration of drug, patent expiry, product recall and patent cliff hampers the growth of the market.
Compotator
The major players covered in the report are Alcoa Corporation, Endurance Technologies Limited, Ryobi Limited, DyCast Specialties Corporation, Consolidated Metco, Inc., Alcast Technologies, Ningbo Beilun Create Mould Machine Co., Ltd, Leggett & Platt, Incorporated, Martinrea Honsel Germany GmbH, Gibbs, Dynacast, Reliance Foundry Co. Ltd., Toyota Industries Corporation, LA Aluminum, TPi Arcade, Drahtwerk Elisental W. Erdmann GmbH & Co., Wagstaff Inc., Ningbo Innovaw Mechanical CO.,LTD., Modern Aluminum Castings CO., INC. and Pacific Die Casting Corp.
Request for Toc@https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-apac-drug-delivery-devices-market
Global Asia Pacific (APAC) Drug Delivery Devices Market Size, Status and Forecast 2018 – 2025
1 Market Overview
2 Manufacturers Profiles
3 Global APAC Cancer Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer
4 Global APAC Cancer Diagnostics Market Analysis by Regions
5 North America Global APAC Cancer Diagnostics by Countries
6 Europe Global Asia Pacific (APAC) Drug Delivery Devices by Countries
7 Asia-Pacific Asia Pacific (APAC) Drug Delivery Devices by Countries
8 South America Global Asia Pacific (APAC) Drug Delivery Devices Diagnostics by Countries
9 Middle East and Africa Global Asia Pacific (APAC) Drug Delivery Devices Diagnostics by Countries
10 APAC Cancer Diagnostics Market Segment by Type
11 Global Asia Pacific (APAC) Drug Delivery Devices Market Segment by Application
12 Global APAC Cancer Diagnostics Market Forecast
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendixes
Based on geography the market is segmented into 7 countries, China, India, Japan, South Korea, Singapore, Australia and rest of APAC. Japan is expected to dominate the market, while China and India are expected to be the growing with highest CAGR in the forecast period.
The report also includes company share analysis for the major companies operating in this market by countries. The details of mergers & acquisitions, product launches, expansions, and product life cycle matrix is also a part of this report. Some of the players in the market Bayer AG, Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, and 3M.
Buynow@https://www.databridgemarketresearch.com/checkout/buy/enterprise/asia-pacific-apac-drug-delivery-devices-market
Reasons to Purchase this Report
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
· Amyotrophic Lateral Sclerosis (ALS) Market
·�� Antifungal Drugs Market
· Cutaneous Lupus Erythematosus Market
0 notes
Text
Auto-injectors Market Highlights Investment Opportunities For Maximum Returns
The global auto-injectors market is predicted to rise at a healthy CAGR during the forecast period. Demand for auto-injectors could show strong growth due to the increase in the incidence of food and skin allergies and anaphylaxis. Patients are observed to prefer using auto-injectors over conventional injection systems because of the advantages of controlled drug delivery, increased efficacy, consistent dose accuracy, decreased risk of needle stick injuries, and reduced needle phobia. Innovation could play a major role in the advancement of auto-injectors.
Late in September 2019, Aterica Digital Health, a Canadian consumer-focused digital health company, announced that its comprehensive anaphylaxis and food allergy support system Veta Smart Case & App is available in Walgreens stores. The Veta system is used for managing epinephrine auto-injectors such as EPIPEN.
Get PDF template of this report: https://www.qyrconsulting.com/request-sample/8133
Leading Companies to Diversify Product Portfolio and Focus on Innovation to Increase Profits
The report covers prominent players of the global auto-injectors market, such as Mylan, Medeca Pharma AB, BD, Antares Pharma, Inc., Johnson & Johnson, Owen Mumford, Amgen Inc., Eli Lilly, Kaleo, Inc., Biogen Idec, Ypsomed Holding, Bayer, and Meridian (Pfizer). Companies are expected to focus on the diversification of their product portfolio, introduction of innovative products, and signing of strategic merger and acquisition agreements to achieve a position of strength in the global auto-injectors market. In May 2019, Ypsomed, a Swiss manufacturer of injection and infusion systems for self-medication, announced that Teva Pharmaceutical Industries launched its drug product Copaxone with the pre-filled auto-injector YpsoMate.
By Product Type
● Disposable Auto-injectors
● Reusable Auto-injectors
By Disease Indication
● Anaphylaxis
● Multiple Sclerosis
● Rheumatoid Arthritis
● Others
Among product type segments, disposable is forecast to secure a significant share of the global auto-injectors market because of its increased adoption. Favorable factors such as high patient preference, convenience, low infection risk, and ease of use are expected to drive the demand for disposable auto-injectors.
Read Report Overview: https://www.qyrconsulting.com/reports/auto-injectors-market
About Us:
QYR Consulting established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.
0 notes
Text
Prefilled Syringes Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
As per the recent study by FutureWise on prefilled syringes, the global market is predicted to value over US$ 10 Bn by the end of the assessment year 2026. Prefilled syringes are utilised to package a variety of medications and drugs, such as vaccines, therapeutic proteins and insulin. In recent years, prefilled syringes have gained colossal demand as it is affordable, accurate, convenient and safe. Healthcare specialists benefit from precise, pre-measured dosages, elimination of medication and dosage errors, and reduced risk of microbial contamination.
Despite holding multiple benefits, factors such as high manufacturing cost of prefilled syringes, storage difficulties, and stringent norms set by government authorities may hinder the growth of the market. Nonetheless, manufacturers should focus on technological improvements and innovations, and catering to the unmet demand for specific syringes as these are the key market growth aspects.
Increase in Prevalence of Chronic Diseases Globally to Augment the Growth of Prefilled Auto Syringes Market
Owing to the rising incidences of chronic diseases globally, healthcare professionals are exploring seeking alternate methods for patient care. As per the Centres for Disease Control and Prevention in 2014, approximately 29.1 million people in the United States were suffering from diabetes, which is 9.3% of the total population. Patients suffering from Type 1 diabetes are advised to undergo periodic intravenous administration of insulin to control their sugar levels inefficiency in natural insulin production. Prefilled syringes assist in self-administration of these drugs by making the treatment affordable, feasible and precise. Due to the rising incidents of chronic diseases in North America, the market displays notable growth.
APEJ region is poised to exhibit growing inclination towards injectable drug delivery systems. The growing ageing population in countries such as India and China, and increasing initiatives in the pharmaceutical industry, is surging the demand for prefilled syringes to treat diabetes and other autoimmune diseases.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=11&page=requestsample
Further Significant Highlights:
Glass prefilled syringes are forecasted to account for the largest market share. The growth of this segment can be associated with the soaring use of glass in manufacturing syringes due to its resistance towards chemical and heat, and nonreactive nature.
Single-chamber prefilled syringes are poised to dominate the market owing to the growing adoption of self-administered parenteral drugs
The market for prefilled syringe manufacturing is concentrated; nevertheless, innovative technologies in packaging material contributed by new players can be adapted to manufacture auto-injectors
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=94&page=askfordiscount
Vital Questions Answered
How rapidly will the prefilled syringes market grow globally?
What are the key factors influencing or restraining the growth of the market?
Key regions to focus on?
Investigating several aspects of the market with the help of Porter’s five forces analysis
Recognising the latest advancements, market shares, and strategies applied by the significant market players
Table of Contents
1. Introduction
1.1. Scope and Objective
1.2. Assumptions and Acronyms
1.3. Forecast Factors
1.4. Research Methodology
2. Executive Summary
2.1. Industry Cluster Analysis
2.2. Competition Matrix
2.3. Strategies Recommendations
3. Market Definition
3.1. Report Scope (Inclusions & Exclusions)
3.2. Market Segmentation
4. Global Pre-Filled Syringes Market Overview
4.1. Global Pre-Filled Syringes Market Revenue (USD Mn)
5. Key Inclusions
5.1. Porter’s Five Force analysis
5.2. Market Dynamics
5.3. Industry Trends
5.4. Regulatory Guidelines
5.5. Opportunities in Pre-Filled Syringes
6. Competition Dynamics
6.1. Company Share Analysis (2018)
6.2. Top 10 Product Pricing by Region
7. Global Pre-Filled Syringes Market Revenue (USD Mn), 2018-2026 by Product Type
7.1. Key Market Findings
7.2. Long Term ROI Segments
7.3. Revenue Opportunity Influencing Factors
7.4. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
7.4.1 Single Chamber Pre-filled Syringe
7.4.2 Dual Chamber Pre-filled Syringe
8. Global Pre-Filled Syringes Market Revenue (USD Mn), 2018-2026 by Material
8.1. Key Market Findings
8.2. Long Term ROI Segments
8.3. Revenue Opportunity Influencing Factors
8.4. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
8.4.1 Glass
8.4.2 Plastic
9. Global Pre-Filled Syringes Market Revenue (USD Mn), 2018-2026 by End User
9.1. Key Market Findings
9.2. Long Term ROI Segments
9.3. Revenue Opportunity Influencing Factors
9.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
9.4.1 Retail Pharmacies
9.4.2 Institutional Distribution
9.4.3 Online Pharmacies
10. Global Pre-Filled Syringes Market Revenue (USD Mn), 2018-2026 by Region
10.1.Key Market Findings
10.2.Long Term ROI Segments
10.3.Revenue Opportunity Influencing Factors
10.4.Market Revenue (USD Mn) Assessment and Forecast by Region,2026
10.4.1 North America
10.4.2 Latin America
10.4.3 Europe
10.4.4 Asia Pacific
10.4.5 Rest of world
11. North America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
11.1. Key Market Findings
11.2. Long Term ROI Segments
11.3. Revenue Opportunity Influencing Factors
11.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
11.4.1 US
11.4.2 Canada
11.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
11.5.3 Single Chamber Pre-filled Syringe
11.5.4 Dual Chamber Pre-filled Syringe
11.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
11.6.5 Glass
11.6.6 Plastic
11.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
11.7.7 Retail Pharmacies
11.7.8 Institutional Distribution
11.7.9 Online Pharmacies
12. Latin America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
12.1. Key Market Findings
12.2. Long Term ROI Segments
12.3. Revenue Opportunity Influencing Factors
12.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Rest of Latin America
12.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
12.5.5 Single Chamber Pre-filled Syringe
12.5.6 Dual Chamber Pre-filled Syringe
12.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
12.6.7 Glass
12.6.8 Plastic
12.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
12.7.9 Retail Pharmacies
12.7.10 Institutional Distribution
12.7.11Online Pharmacies
13. Europe America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
13.1. Key Market Findings
13.2. Long Term ROI Segments
13.3. Revenue Opportunity Influencing Factors
13.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
13.4.1 Germany
13.4.2 France
13.4.3 Spain
13.4.4 UK
13.4.5 Russia
13.4.6 Poland
13.4.7 Rest of Europe
13.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
13.5.8 Single Chamber Pre-filled Syringe
13.5.9 Dual Chamber Pre-filled Syringe
13.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
13.6.10 Glass
13.6.11 Plastic
13.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
13.7.12 Retail Pharmacies
13.7.13 Institutional Distribution
13.7.14 Online Pharmacies
14. Asia Pacific America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
14.1. Key Market Findings
14.2. Long Term ROI Segments
14.3. Revenue Opportunity Influencing Factors
14.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
14.4.1 Emerging Asia
14.4.1.1 China
14.4.1.2 India
14.4.1.3 ASEAN-5
14.4.1.4 Rest of Emerging Asia
14.4.2 Japan
14.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
14.5.3 Single Chamber Pre-filled Syringe
14.5.4 Dual Chamber Pre-filled Syringe
14.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
14.6.5 Glass
14.6.6 Plastic
14.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
14.7.7 Retail Pharmacies
14.7.8 Institutional Distribution
14.7.9 Online Pharmacies
15. Rest of World America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
15.1. Key Market Findings
15.2. Long Term ROI Segments
15.3. Revenue Opportunity Influencing Factors
15.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
15.4.1 Middle East
15.4.2 South Africa
15.4.3 North Africa
15.4.4 Rest of World
15.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
15.5.5 Single Chamber Pre-filled Syringe
15.5.6 Dual Chamber Pre-filled Syringe
15.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
15.6.7 Glass
15.6.8 Plastic
15.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
15.7.9 Retail Pharmacies
15.7.10 Institutional Distribution
15.7.11 Online Pharmacies
16. Company Profiles
16.1. Competition Landscape
16.2. Global Company Share (USD Mn) Overview, 2018
16.3. Company Profiles
16.3.1 Mylan N.V.
16.3.1.1 Corporate Overview
16.3.1.2 Financial Performance
16.3.1.3 Peer Comparison & 3C marketing equation
16.3.1.4 Company Strategy & Channel Management
16.3.2 Amedra Pharmaceuticals LLC
16.3.2.1 Corporate Overview
16.3.2.2 Financial Performance
16.3.2.3 Peer Comparison & 3C marketing equation
16.3.2.4 Company Strategy & Channel Management
16.3.3 Owen Mumford
16.3.3.1 Corporate Overview
16.3.3.2 Financial Performance
16.3.3.3 Peer Comparison & 3C marketing equation
16.3.3.4 Company Strategy & Channel Management
16.3.4 Ypsomed AG
16.3.4.1 Corporate Overview
16.3.4.2 Financial Performance
16.3.4.3 Peer Comparison & 3C marketing equation
16.3.4.4 Company Strategy & Channel Management
16.3.5 Antares Pharma
16.3.5.1 Corporate Overview
16.3.5.2 Financial Performance
16.3.5.3 Peer Comparison & 3C marketing equation
16.3.5.4 Company Strategy & Channel Management
16.3.6 SHL Group
16.3.6.1 Corporate Overview
16.3.6.2 Financial Performance
16.3.6.3 Peer Comparison & 3C marketing equation
16.3.6.4 Company Strategy & Channel Management
16.3.7 Johnson & Johnson
16.3.7.1 Corporate Overview
16.3.7.2 Financial Performance
16.3.7.3 Peer Comparison & 3C marketing equation
17. Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: [email protected] Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com
#Prefilled Syringes Market Share#Prefilled Syringes Market Size#Prefilled Syringes Market Trend#Prefilled Syringes Market Forecast#Prefilled Syringes Market
0 notes
Text
Novartis to promote epinephrine shot in U.S. pharmacies amid EpiPen scarcity
http://tinyurl.com/y4mnywrc (Reuters) – Novartis AG (NOVN.S) mentioned on Tuesday it will make its generic pre-filled epinephrine photographs instantly out there in native pharmacies throughout the US, as a scarcity of Mylan NV’s (MYL.O) EpiPen emergency allergy therapy drags on resulting from manufacturing issues. FILE PHOTO: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical firm to be used by extreme allergy victims are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photograph Novartis’ Sandoz unit launched the Symjepi epinephrine photographs to be used in hospitals in January and had mentioned it will make the therapy out there in pharmacies in a phased method. The Swiss drugmaker has an unique settlement with Adamis Prescription drugs Corp (ADMP.O) to distribute and commercialize Symjepi in the US. Novartis mentioned each the grownup and pediatric doses of Symjepi can be instantly out there in native U.S. pharmacies. The wholesale worth for a two-pack of adult-dose syringes is $250, Novartis mentioned, beneath the $300 charged by Mylan for its licensed generic and for Teva’s (TEVA.TA) generic model of the EpiPen auto-injector. Mylan nonetheless dominates the marketplace for emergency allergy photographs with its EpiPen that delivers a dose of epinephrine within the occasion of extreme, doubtlessly life-threatening allergic reactions to quite a few triggers, resembling bee stings or peanuts. However there was a scarcity of EpiPens in the US, Europe and Canada resulting from manufacturing delays. The U.S. Meals and Drug Administration added the therapy to its checklist of medication in scarcity greater than a yr in the past, and it stays on that checklist. Pfizer Inc’s (PFE.N) Meridian Medical unit, which produces all EpiPens bought globally at a single plant close to St. Louis, has been hit by a collection of producing issues. The corporate mentioned in a press release on Tuesday that it anticipates additional provide shortages over the approaching months. There’s historically excessive demand for the gadgets in the summertime as households look to resume prescriptions forward of sending kids to summer time camp or the brand new faculty yr. Teva has constructed important market share with its generic this yr, reaching 18% of the market in late June, in response to a analysis observe from Leerink that cited IQVIA (IQV.N) prescription quantity information. Teva mentioned in Might it anticipated to achieve round 20% market share by the top of the second quarter and will method 50% market share by the top of the yr. Reporting by Aakash Jagadeesh Babu and Tamara Mathias in Bengaluru and Michael Erman in New York; Enhancing by Maju Samuel and Invoice Berkrot Our Requirements:The Thomson Reuters Trust Principles. Source link
0 notes
Text
Interview Released with James Mellman, Novartis
SMI REPORTS: SMi Group speak to James Mellman, Device Manager, Novartis, Co-Chair of Pre-Filled Syringes 2019
SMi Group are delighted to have James Mellman, Device Manager, Novartis, Co-Chair the 11th annual conference and exhibition on Pre-Filled Syringes & Injectable Drug Devices when it returns to Central London on 16th and 17th January 2019.
James is a device manager for Novartis in Basel, Switzerland. His main responsibilities include developing primary packaging systems for combination products and supporting new technologies. He has worked on a multitude of injection device platforms including pre-filled syringes, needle safety devices, auto injectors, and patch injectors. He has also helped to build and implement a renovated CCIT strategy for the Novartis Group.
Before Novartis, James worked at Pfizer in their Devices Center of Excellence in Cambridge, UK (2008-2011) and Nutricia in their Advanced Medical Nutrition Division HQ in Amsterdam, NL (2011-2014). He received his PhD from the University of Florida in Materials Science & Engineering in 2007 specializing in biomaterials.
In the run-up to the event, we caught up with him to discuss current industry hurdles and the upcoming conference. From the answers provided it is apparent that the growing usage of prefilled syringes and technological advancements in auto-injectors are key factors driving the market today.
As well as Co-Chairing Pre-Filled Syringes Europe alongside Anil Busimi, Strategy and Innovation Global Product Manager, SCHOTT will also be leading an industry-led panel discussion with GSK, and MSD. The event spotlight on regulation will also include an exclusive keynote address from the MHRA.
Here is a snap shot of the interview:
What is your area of expertise within the Pre-filled Syringes market?
“My expertise comes from working at Novartis since 2014. I worked on a number of projects for both development and commercial products, and this has allowed me to get to know the issues, supply chain, and best practices in the field. A great interest of mine is evaluating compatibility between drug products and their delivery system.”
What do you hope to gain from this meeting?
“I hope to learn from the great work from others who are presenting as well as the discussions that follow.”
The full interview is available online in the event download centre.
SMi’s 11th annual 2018 Pre-Filled Syringes & Injectable Drug Devices Europe conference and exhibition will take place on 16th & 17th Jan at the Copthorne Tara Hotel, Kensington, London UK.
Further information including a detailed agenda and full speaker line-up is available at http://www.pre-filled-syringes.com/pjpr3
— ENDS —
Contact Information:
For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 688 / Email: [email protected]
Sponsors of Pre-Filled Syringes Europe 2019 include:
Eveon, Fruh, Harro Hoefliger, Mitsubishi Gas Chemical, Mikron, Nemera, Nelson labs, Nipro PharmaPackaging, Owen mumford, PHC Corporation, Schott, Zeon, Zwick Testing Machines
For details email director Alia Malick at [email protected]
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
The post Interview Released with James Mellman, Novartis appeared first on Pharmaphorum.
from Pharmaphorum https://pharmaphorum.com/partner-content/interview-released-with-james-mellman-novartis/
0 notes
Text
Pre-filled Syringes Market to Witness Widespread Expansion by 2024
Syringe filled with fixed dosage of therapeutic drug is known as prefilled syringe. The devices are used for delivering drugs with efficient efficacy, accuracy, safety, convenience, sterility, affordability and accessibility. The above features make pre-filled syringes more advantageous than traditional methods of drug delivery. Moreover, prefilled syringe decrease contamination and possible dosing errors.
The technological advancements in the pre-filled syringes, increasing prevalence of chronic diseases, and large population base are the major factors driving the growth of the pre-filled syringes market. Furthermore, the key players are establishing production facilities in both developed and emerging markets which will further boost the growth of the market. However, the growth of the prefilled syringes is hindered with low awareness among consumers and few product recalls.
Request for a sample of report @
https://mindaspiremarketresearch.com/request-sample/report/cha-market-analysis
The pre-filled syringes market is witnessing development of technologically advanced pre-filled syringes and growing usage of self-injection devices as major trends. For instance, in July 2015, Vetter introduced Vetter-Ject, a new closure system for its prefilled syringes. This syringe system is suitable for filling of highly sensitive drug molecules. Similarly, earlier, in April, 2015, SCHOTT lauched a new polymer pre-filled syringe design—SCHOTT TopPac. The design was aimed at improving the safety and stability of the sensitive drug molecules. Moreover, many pharmaceutical companies are focusing on bringing in advancements in self administration therapies. In this direction, in August, 2016, Mylan N.V., through its U.S. subsidiary, launched the first generic EpiPen Auto-Injector . Similarly, in July 2016, Bristol-Myers Squibb commercially introduced the ORENCIA ClickJect Auto injector.
The Global Prefilled Syringes Market was valued at $3.7 billion in 2017, and is estimated to reach $7.6 billion by 2024, registering a CAGR of 9.7% from 2018 to 2024.
Global Pre-filled Syringes Market: Segmentation
By Material
Glass-based
Plastic-based
By Design
Single-chamber Prefilled Syringes
Dual-chamber Prefilled Syringes
Customized Prefilled Syringes
By Application
Anaphylaxis
Rheumatoid Arthritis
Diabetes
Others (Cancer, Multiple Sclerosis, and others)
Geographically, the global prefilled syringes market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2017, Europe commanded a major share of the prefilled syringes market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the increasing demand for self-administered treatments and high penetration of self-injection devices, growing aging population, and increasing prevalence of diabetes.
Ask an Analyst @
https://mindaspiremarketresearch.com/inquire/report/cha-market-analysis
Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), and MedPro Inc. (U.S.) are some of the key players in the prefilled syringes market.
0 notes